William Jacobsen
Keine laufenden Positionen mehr
Profil
William Jacobsen worked as a Director-Technical Operations & Site at EMD Serono, Inc., a Principal at Transkaryotic Therapies, Inc., a Principal at Genzyme Corp., and a Principal at Marathon Biopharmaceuticals.
He obtained an undergraduate degree from The State University of New York.
Ehemalige bekannte Positionen von William Jacobsen
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | - |
Marathon Biopharmaceuticals
 Marathon Biopharmaceuticals BiotechnologyHealth Technology Part of Cambrex Corp., Marathon Biopharmaceuticals is a company that manufactures biopharmaceutical ingredients and purified bulk biologics for pre-clinical evaluation. The company is based in Hopkinton, MA. Marathon Biopharmaceuticals was acquired by Cambrex Corp. from CoPharma, Inc. on October 30, 2001 for $26 million. | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von William Jacobsen
| The State University of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Marathon Biopharmaceuticals
Marathon Biopharmaceuticals BiotechnologyHealth Technology Part of Cambrex Corp., Marathon Biopharmaceuticals is a company that manufactures biopharmaceutical ingredients and purified bulk biologics for pre-clinical evaluation. The company is based in Hopkinton, MA. Marathon Biopharmaceuticals was acquired by Cambrex Corp. from CoPharma, Inc. on October 30, 2001 for $26 million. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
